Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Century Therapeutics launches to develop stem cell-derived, gene-edited cell therapies for cancer

The start-up has raised $250 million, the majority of which came from Bayer, to make off-the-shelf cell therapies from induced pluripotent stem cells

by Ryan Cross
July 2, 2019 | A version of this story appeared in Volume 97, Issue 27

Article:

This article has been sent to the following recipient: